Olea europaea leaf
1 paper3 findings
- 1 lab in 1 country
- Human trial1
Outcomes
3MMP2
no changein humans1
1 study
MMP2
no changein humans1
Olea europaea leaf has no effect on MMP2 in humans.
“Collagen, hydroxyproline, MMP-2, and glucose remained unaffected.”
Human trialhealthy250 mg daily12 weeksfemalesn = 65
Frontiers in nutrition18 Nov 2025
Pentosidine
downin humans1
1 study
Pentosidine
downin humans1
Olea europaea leaf decreases pentosidine in humans (-0.75 [-1.40; -0.11]).
“Pentosidine significantly decreased in the OLE group compared to placebo [-0.75 [-1.40; -0.11], p = 0.022], but also not after correction (p adj = 0.088).”
Human trialhealthy250 mg daily12 weeksfemalesn = 65
Frontiers in nutrition18 Nov 2025
Pore number
downin humans1
1 study
Pore number
downin humans1
Olea europaea leaf decreases pore number in humans (-7.86 [0.64; 15.07]).
“At week 12, the OLE group had a significantly lower pore number compared to placebo [-7.86, [0.64; 15.07], p = 0.034].”
Human trialhealthyskin250 mg daily12 weeksfemalesn = 26
Frontiers in nutrition18 Nov 2025
Latest
1 in 12 monthsFrontiers in Nutrition
Effects of olive leaf extract supplementation on systemic markers of tissue aging and remodeling in postmenopausal women: a randomized controlled trial with exploratory skin outcomes
Randomised trial in 65 peopleSkin